NCT04387656

NCI COVID-19 in Cancer Patients, NCCAPS Study

RecruitingOBSERVATIONAL

Trial Details

Start: 2020-06-05Est. Completion: 2024-03-20

Enrollment target: 1,877 participants

Locations

University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
Veterans Administration Medical Center - Birmingham, Birmingham, Alabama, United States
USA Health Strada Patient Care Center, Mobile, Alabama, United States
Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States
Anchorage Radiation Therapy Center, Anchorage, Alaska, United States
Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States
Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States
Alaska Women's Cancer Care, Anchorage, Alaska, United States
Anchorage Oncology Centre, Anchorage, Alaska, United States
Katmai Oncology Group, Anchorage, Alaska, United States
Providence Alaska Medical Center, Anchorage, Alaska, United States
Fairbanks Memorial Hospital, Fairbanks, Alaska, United States
Kingman Regional Medical Center, Kingman, Arizona, United States
Banner Children's at Desert, Mesa, Arizona, United States
Cancer Center at Saint Joseph's, Phoenix, Arizona, United States

SARS-CoV-2

The primary purpose of this study is to evaluate the efficacy and safety of secutrelvir in symptomatic nonhospitalized a…

Coral Gables, United StatesEst. completion Jun 30, 2028

Healthy

Background: Infections in the lower respiratory tract (lungs) are the leading cause of death from infectious disease wo…

Hamilton, United StatesEst. completion Oct 31, 2033

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.